Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fMRI Study of D-cycloserine in Spider Phobia
NCT00591825Phase 2Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Mar 2006
- Primary completion
- Dec 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of d-cycloserine in Specific phobia animal type (4 arms), sponsored by University of Kansas Medical Center. Primary endpoint: fMRI Brain Activations During Symptom Provocation at 2 weeks. Started Mar 2006; status: completed.
02
Drugs
d-cycloserine
03
Conditions
Specific phobia animal type
Beyond the preview
Go deeper on NCT00591825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00591825.